🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Lulu Chirande

Muhimbili University of Health and Allied Sciences

ORCID: 0009-0001-5008-3786

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 4 papers. Top paper: “Barriers and Facilitators of Use of Hydroxyurea among Children with Sickle Cell Disease: Experiences of Stakeholders in Tanzania”.

Barriers and Facilitators of Use of Hydroxyurea among Children with Sickle Cell Disease: Experiences of Stakeholders in Tanzania

Hemato(2021)10.3390/hemato2040048

N/A

0.489DataRank · unranked

25 citations

Hamu J. Mlyuka, Fatuma Felix Felician, Dorkasi L. Mwakawanga, Lulu Chirande, David T. Myemba +11 more

Global perspectives on cellular therapy for children with sickle cell disease

Current Opinion in Hematology(2022)10.1097/moh.0000000000000738

N/A

0.425DataRank · unranked

16 citations

Ruth Namazzi, Lulu Chirande, Venée N. Tubman, Tami John

Acceptability, barriers and facilitators of using dried blood spots-point-of-care testing for sickle cell disease in Africa: an implementation science protocol for a multinational qualitative study

BMJ Open(2024)10.1136/bmjopen-2024-089056

N/A

0.373DataRank · unranked

11 citations

Nchangwi Syntia Munung, Lulu Chirande, Catherine Chunda‐Liyoka, Sarah Kiguli, Fred Stephen Sarfo +18 more

Promoting access of hydroxyurea to sickle cell disease individuals: Time to make it an essential medicine

F1000Research(2022)10.12688/f1000research.111300.1

N/A

0DataRank · unranked

2 citations

Hamu J. Mlyuka, Agnes Jonathan, Hilda Tutuba, Lulu Chirande, Paschal Rugajo +5 more